Stuart Kolinski, SVP General Counsel and Secret at REGENERON PHARMACEUTICALS INC (REGN), sold 12,314 shares at $27.66 ($337K) on 2010-02-03, disclosed to the SEC on 2010-02-04.
Scheduled sale ($337k) by SVP General Counsel and Secret under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.16 | 103 | $3K | 0.8% |
| 2 | $27.16 | 129 | $4K | 1.0% |
| 3 | $27.16 | 785 | $21K | 6.3% |
| 4 | $27.16 | 988 | $27K | 8.0% |
| 5 | $27.16 | 2,174 | $59K | 17.5% |
| 6 | $27.16 | 2,734 |
| $74K |
| 22.0% |
| 7 | $27.66 | 4,951 | $137K | 40.6% |
| 8 | $28.08 | 450 | $13K | 3.7% |
| Total | $27.39 avg | 12,314 | $337K | 100% |
| Filing → |
| REGN | SELL | 2006-08-18 | $30K | — | Filing → |
| REGN | SELL | 2006-01-10 | $28K | — | Filing → |